Last update 01 Nov 2024

ARQ-171

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
E2F1
Mechanism
E2F1 stimulants(Transcription factor E2F1 stimulants)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmNeoplasmsSolid tumor
Originator Organization
ArQule, Inc.ArQule, Inc.
Active Organization-
Inactive Organization
ArQule, Inc.ArQule, Inc.Merck GmbH
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ARQ-171
NCT00398840 / TerminatedPhase 1
A Phase 1 Dose Escalation Study of ARQ 171 in Adult Patients With Advanced Solid Tumors
100 Clinical Results associated with ARQ-171
Login to view more data
100 Translational Medicine associated with ARQ-171
Login to view more data
100 Patents (Medical) associated with ARQ-171
Login to view more data
100 Deals associated with ARQ-171
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
US
-01 Nov 2006
NeoplasmsPhase 1
US
ArQule, Inc.ArQule, Inc.
01 Nov 2006
Solid tumorPhase 1
US
Merck GmbH
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free